Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study
2016 · The Lancet Infectious Diseases · 179 citations
https://doi.org/10.1016/s1473-3099(16)00074-8
A
Andrew Akampurira
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
46
Papers
1.4K
Citations
18
h-index
25
i10-index
Andrew Akampurira is an academic researcher from Infectious Diseases Institute. The author has contributed to research in topics: Fungal Infections and Studies & Antifungal resistance and susceptibility & Nail Diseases and Treatments. The author has an h-index of 18, co-authored 40 publications.
Papers by this author
worksAdjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial
2019 · The Lancet Infectious Diseases · 122 citations
https://doi.org/10.1016/s1473-3099(19)30127-6
Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial
2019 · The Lancet Infectious Diseases · 122 citations
https://doi.org/10.1016/s1473-3099(19)30127-6
Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial
2023 · Clinical Infectious Diseases · 55 citations
https://doi.org/10.1093/cid/ciad440
Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitis
2017 · BMC Microbiology · 13 citations
https://doi.org/10.1186/s12866-017-1093-4
Impact of community engagement and social support on the outcomes of HIV-related meningitis clinical trials in a resource-limited setting
2020 · Research Involvement and Engagement · 13 citations
https://doi.org/10.1186/s40900-020-00228-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat